Ursodeoxycholic Acid at 18–22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis

AIM: To compare the response between the current recommended dosage 13–15 mg/kg/d and 20 mg/kg/d dose of ursodeoxycholic acid (UDCA) in primary biliary cholangitis (PBC) patients who do not respond completely to a standard dose of UDCA. METHODS: We included 73 patients with poor response and randomi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Can J Gastroenterol Hepatol
Egile Nagusiak: Xiang, Xinyu, Yang, Xiaoli, Shen, Mengyi, Huang, Chen, Liu, Yifeng, Fan, Xiaoli, Yang, Li
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2021
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7843178/
https://ncbi.nlm.nih.gov/pubmed/33542908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6691425
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak